Christine A. Edwards

Christine A. Edwards

Auto-generated profile, based on publicly available information

Christine A. Edwards

School of Engineering, Deakin University, Geelong, VIC 3216, Australia. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States of America. Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, United States of America

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
CEChristine A. Edwards
Christine A. Edwards
AKAbbas Kouzani
Abbas Kouzani
KLKendall H. Lee
Kendall H. Lee
ERErika Ross
Erika Ross

11 September 2018 in Journal of Neural Engineering
Verified
Journal Article
Closed access
PDF file
CEChristine A Edwards
Christine A Edwards
ARAaron E Rusheen
Aaron E Rusheen
YOYoonbae Oh
Yoonbae Oh
SPSeungleal B Paek
Seungleal B Paek
JJJoshua Jacobs
Joshua Jacobs
SGStephan J Goerss
Stephan J Goerss
Objective . Stereotactic frame systems are the gold-standard for stereotactic surgeries, such as implantation of deep brain stimulation (DBS) devices for treatment of medically resistant neurologic and psychiatric disorders. However, frame-based systems require that the patient is awake with a stereotactic frame affixed to their head for the duration of the surgical planning and implantation of the DBS electrodes. While frameless systems are increasingly available, a reusable re-attachable frame system provides unique benefits. As such, we created a novel reusable MRI-compatible stereotactic frame system that maintains clinical accuracy through the detachment and reattachment of its stereotactic devices used for MRI-guided neuronavigation. Approach . We designed a reusable arc-centered frame system that includes MRI-compatible anchoring skull screws for detachment and re-attachment of its stereotactic devices. We validated the stability and accuracy of our system through phantom, in vivo mock-human porcine DBS-model and human cadaver testing. Main results . Phantom testing achieved a root mean square error (RMSE) of 0.94 ± 0.23 mm between the ground truth and the frame-targeted coordinates; and achieved an RMSE of 1.11 ± 0.40 mm and 1.33 ± 0.38 mm between the ground truth and the CT- and MRI-targeted coordinates, respectively. In vivo and cadaver testing achieved a combined 3D Euclidean localization error of 1.85 ± 0.36 mm ( p < 0.03) between the pre-operative MRI-guided placement and the post-operative CT-guided confirmation of the DBS electrode. Significance . Our system demonstrated consistent clinical accuracy that is comparable to conventional frame and frameless stereotactic systems. Our frame system is the first to demonstrate accurate relocation of stereotactic frame devices during in vivo MRI-guided DBS surgical procedures. As such, this reusable and re-attachable MRI-compatible system is expected to enable more complex, chronic neuromodulation experiments, and lead to a clinically available re-attachable frame that is expected to decrease patient discomfort and costs of DBS surgery.